Table 1.
Assertion edge type | Name | Relationship | Reference | Nodes/nodes/edges |
---|---|---|---|---|
Birth defect–gene | HPO | Genes known to be associated with a birth defect | Human Phenotype Ontology | 599/5093/127,023 |
Geneshot | Genes co-mentioned with birth-defect terms in publications | Geneshot | 32/1091/1565 | |
Birth defect–drug | FDA Adverse Event Reporting System (Female/Male) | Drugs with reported adverse events related to birth defects | FDA Adverse Event Reporting System | 32/94/372 |
Drugshot | Drugs co-mentioned with birth-defect terms in publications | Drugshot | 679/2207/13,000 | |
Drug–gene | IDG (Drug Target) | Drugs with known human gene targets | Target Central Resource Database | 1363/1034/7326 |
SigCom LINCS Drug-to-Gene (upregulates/ downregulates) | Drugs that up- or down-regulate genes across the LINCS L1000 signatures | SigCom LINCS | 4523/4419/225,509 | |
Drug–drug | LINCS Drugs Cosine Similarity | Drugs that induce similar gene expression patterns across LINCS L1000 signatures based on cosine similarity | SigCom LINCS | 4523/3449/20,785 |
Gene–gene | ARCHS4 (positively/ negatively correlated) | Genes positively or negatively correlated across ARCHS4 gene expression samples | ARCHS4 | 17,964/12,185/ 170,801 |
The ReproTox-KG is made of entities (nodes) representing birth defects, genes, and drugs that are connected based on semantic assertions (edges/relationships) extracted from different sources. The table lists the type of assertion, the nature of the relationship, the original source from where the assertion was extracted from, and the number of entities and relations for each entry in the table.